logo

For the Inventor, By the Inventor

Nyack, NY, United States of America

Jamie Marie Davis

This inventor holds 9 USPTO granted patents. Top assignees: American Cyanamid Company, Wyeth, American Home Products Corporation. Active years: 2001-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jamie Marie Davis. Retrieved from https://idiyas.com/inventor/jamie-marie-davis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 44.4

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 58(Granted Patents)


Location History:

  • Nyack, NY (US) (2001 - 2004)
  • Ann Arbor, MI (US) (2005 - 2008)

Company Filing History:

goldMedal4 out of 3,580 
 
American Cyanamid Company
 patents
silverMedal3 out of 1,309 
 
Wyeth
 patents
bronzeMedal1 out of 1,567 
 
American Home Products Corporation
 patents
4. 1 out of 113 
 
Wyeth Holdings Corporation
 patents

Years Active: 2001-2008

Loading Chart...
9 patents (USPTO):Explore Patents
1. 7332506 - Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression (2008-02-19),
2. 7148235 - Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression (2006-12-12),
3. 6939870 - Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression (2005-09-06),
4. 6825354 - Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitors (2004-11-30),
5. 6462073 - N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors (2002-10-08),
6. 6342508 - N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors (2002-01-29),
7. 6340691 - Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors (2002-01-22),
8. 6197791 - N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors (2001-03-06),
9. 6172057 - N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors (2001-01-09),

Title: Jamie Marie Davis: Innovator in Neurological Treatments

Introduction

Jamie Marie Davis is a notable inventor based in Nyack, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of depression. With a total of 9 patents to his name, Davis has established himself as a key figure in the development of innovative compounds aimed at improving mental health.

Latest Patents

Among his latest patents, Davis has developed substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression. This compound is represented by a specific formula, wherein A denotes various heterocycles. The patent details a composition containing this compound and outlines methods for treating disorders of the serotonin-affected neurological systems utilizing such a compound or composition. This innovative approach highlights his commitment to addressing complex neurological issues.

Career Highlights

Throughout his career, Jamie Marie Davis has worked with prominent companies in the pharmaceutical industry, including American Cyanamid Company and Wyeth. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field.

Collaborations

Davis has collaborated with several talented individuals, including Aranapakam Mudumbai Venkatesan and George Theodore Grosu. These partnerships have further enhanced his work and led to advancements in his research.

Conclusion

In summary, Jamie Marie Davis is a distinguished inventor whose work in the treatment of depression has made a significant impact on the pharmaceutical industry. His innovative patents and collaborations reflect his dedication to improving mental health through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…